BioCentury | Mar 23, 2015
Financial News

Alize Pharma completes venture financing

Alize Pharma , Lyon, France Business: Endocrine/Metabolic Date completed: 2015-03-17 Type: Venture financing Raised: EUR1.8 million ($1.9 million) Investors: Sofimac; Octalfa S.A.S.; Sham; Rhone Alpes Creation; Credit Agricole; CEMA Inc.; TAB Consulting Note: Alize Pharma’s Alize...
BioCentury | Jan 27, 2014
Financial News

Synthelis completes venture financing

Synthelis , La Tronche, France Business: Proteomics, Supply/Service Date completed: 1/21/14 Type: Venture financing Raised: €610,000 ($826,916) Investors: Rhone Alpes Creation; Alpes Developpement Durable Investissement; Sud Rhone-Alpes Capital; Viaduc; angel investors WIR Staff...
BioCentury | Mar 5, 2007
Strategy

Trans-Atlantic play

...Thus, OPi's investors have made at least six times their investment. Shareholders include Sofimac Partners, Rhone-Alpes Creation...
Items per page:
1 - 3 of 3
BioCentury | Mar 23, 2015
Financial News

Alize Pharma completes venture financing

Alize Pharma , Lyon, France Business: Endocrine/Metabolic Date completed: 2015-03-17 Type: Venture financing Raised: EUR1.8 million ($1.9 million) Investors: Sofimac; Octalfa S.A.S.; Sham; Rhone Alpes Creation; Credit Agricole; CEMA Inc.; TAB Consulting Note: Alize Pharma’s Alize...
BioCentury | Jan 27, 2014
Financial News

Synthelis completes venture financing

Synthelis , La Tronche, France Business: Proteomics, Supply/Service Date completed: 1/21/14 Type: Venture financing Raised: €610,000 ($826,916) Investors: Rhone Alpes Creation; Alpes Developpement Durable Investissement; Sud Rhone-Alpes Capital; Viaduc; angel investors WIR Staff...
BioCentury | Mar 5, 2007
Strategy

Trans-Atlantic play

...Thus, OPi's investors have made at least six times their investment. Shareholders include Sofimac Partners, Rhone-Alpes Creation...
Items per page:
1 - 3 of 3